Abstract
a Monash Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, VIC 3004, Australia b Department of Cardiology B, Oslo University Hospital Ulleval, 0407 Oslo, Norway c Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway d Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, VIC 3068 Australia e Novartis Pharmaceuticals Corp., Development Franchise — Critical Care, East Hanover, USA f Novartis Pharma DS&E and Oncology, Drug Safety and Epidemiology, Basel, Switzerland
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
